Skip to main content
. 2023 Aug 2;80(9):914–923. doi: 10.1001/jamapsychiatry.2023.2345

Table 1. Descriptive Statistics of Study Participants.

Variable Participantsa
Placebo (n = 63) 5.9% or 13.4% THC (n = 121)
Age, mean (SD), y 28.1 (7.25) 31.0 (8.65)
Sex
Female 31 (49.2) 36 (29.8)
Male 32 (50.8) 85 (70.2)
Educational level, mean (SD), y 15.0 (1.93) 15.0 (2.04)
Race and ethnicity
African American 8 (12.7) 9 (7.4)
Asian 5 (7.9) 11 (9.1)
Hispanic 15 (23.8) 40 (33.1)
Indigenous 5 (7.9) 3 (2.5)
Non-Hispanic White 28 (44.4) 52 (43.0)
Multiracial 2 (3.2) 4 (3.3)
Unknown 0 2 (1.7)
Distance driven in previous year, median (IQR), mi 8730 (5420-12 825) 8960 (5048-13 290)
Cannabis use
Current use <4 times/wk 34 (54.0) 62 (51.2)
Days used in past 30 d, mean (SD), No. 16.9 (9.69) 16.6 (9.94)
Amount used in past 30 d, median (IQR), g/d 0.55 (0.25-1.00) 0.55 (0.25-1.00)
Time since last use, median (IQR), d 3.00 (3.00-6.00) 3.00 (2.50-4.00)

Abbreviation: THC, Δ9-tetrahydrocannabinol.

a

Data are presented as the number (percentage) of participants unless otherwise indicated.